Publications by Cristina Al-Khalili Szigyarto
Peer reviewed
Articles
[1]
R. Rossi et al., "A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma : Implications in DMD Diagnosis and Clinical Monitoring," International Journal of Molecular Sciences, vol. 24, no. 6, 2023.
[2]
C. Johansson et al., "Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers," Clinical Proteomics, vol. 20, no. 1, 2023.
[3]
R. Rossi et al., "Circadian Genes as Exploratory Biomarkers in DMD : Results From Both the mdx Mouse Model and Patients," Frontiers in Physiology, vol. 12, 2021.
[4]
M. Signorelli et al., "Penalized regression calibration : A method for the prediction of survival outcomes using complex longitudinal and high-dimensional data," Statistics in Medicine, vol. 40, no. 27, pp. 6178-6196, 2021.
[5]
M. S. Falzarano et al., "Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases," Frontiers in Physiology, vol. 12, 2021.
[6]
K. Strandberg et al., "Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy," Journal of Neuromuscular Diseases, vol. 7, no. 3, pp. 231-246, 2020.
[7]
C. Al-Khalili Szigyarto, "Duchenne Muscular Dystrophy : recent advances in protein biomarkers and the clinical application," Expert Review of Proteomics, vol. 17, no. 5, pp. 365-375, 2020.
[8]
S. A. Kennedy et al., "Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D," Nature Communications, vol. 11, no. 1, 2020.
[9]
M. Signorelli et al., "Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy," Journal of Cachexia, Sarcopenia and Muscle, vol. 11, no. 2, pp. 505-517, 2020.
[10]
S. C. Previtali et al., "Rimeporide as a first- in-class NHE-1 inhibitor : Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy," Pharmacological Research, vol. 159, 2020.
[11]
C. Passarelli et al., "Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy," Frontiers in Genetics, vol. 11, 2020.
[12]
E. Fasterius, M. Uhlén and C. Al-Khalili Szigyarto, "Single-cell RNA-seq variant analysis for exploration of genetic heterogeneity in cancer," Scientific Reports, vol. 9, 2019.
[13]
T. Charitou et al., "Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS(G13D) mutation," British Journal of Cancer, vol. 121, no. 1, pp. 37-50, 2019.
[14]
A. Aartsma-Rus et al., "226th ENMC International Workshop: : Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands," Neuromuscular Disorders, vol. 28, no. 1, pp. 77-86, 2018.
[15]
E. Fasterius and C. Al-Khalili Szigyarto, "Analysis of public RNA-sequencing data reveals biological consequences of genetic heterogeneity in cell line populations," Scientific Reports, vol. 8, 2018.
[16]
C. A. Szigyarto and P. Spitali, "Biomarkers of Duchenne muscular dystrophy : current findings," Degenerative Neurological and Neuromuscular Disease, vol. 8, pp. 1-13, 2018.
[17]
F. Edfors et al., "Enhanced validation of antibodies for research applications," Nature Communications, vol. 9, 2018.
[18]
E. Fasterius and C. Al-Khalili Szigyarto, "SeqCAT : A bioconductor R-package for variant analysis of high throughput sequencing data [version 1; peer review: 1 approved with reservations, 1 not approved]," F1000 Research, vol. 7, 2018.
[19]
P. Spitali et al., "Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies," Journal of Cachexia, Sarcopenia and Muscle, vol. 9, no. 4, pp. 715-726, 2018.
[20]
F. Danielsson et al., "Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia," Oncotarget, vol. 9, no. 28, pp. 19730-19744, 2018.
[21]
E. Fasterius et al., "A novel RNA sequencing data analysis method for cell line authentication," PLOS ONE, vol. 12, no. 2, 2017.
[22]
A. Lourbakos et al., "Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne," Scientific Reports, vol. 7, 2017.
[23]
M. Uhlén et al., "Tissue-based map of the human proteome," Science, vol. 347, no. 6220, pp. 1260419, 2015.
[24]
L. Fagerberg et al., "Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics," Molecular & Cellular Proteomics, vol. 13, no. 2, pp. 397-406, 2014.
[25]
N. Wein et al., "Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice," Nature Medicine, vol. 20, no. 9, pp. 992-1000, 2014.
[26]
D. Cepeda et al., "CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer," EMBO Molecular Medicine, vol. 5, no. 7, pp. 999-1018, 2013.
[27]
L. Fagerberg et al., "Contribution of antibody-based protein profiling to the human chromosome-centric proteome project (C-HPP)," Journal of Proteome Research, vol. 12, no. 6, pp. 2439-2448, 2013.
[28]
C. E. Ström et al., "Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate," Nucleic Acids Research, vol. 39, no. 8, pp. 3166-3175, 2011.
[29]
C. Al-Khalili Szigyarto et al., "The E3 Ligase Axotrophin/MARCH-7 : Protein Expression Profiling of Human Tissues Reveals Links to Adult Stem Cells," Journal of Histochemistry and Cytochemistry, vol. 58, no. 4, pp. 301-308, 2010.
[30]
G. Ahlin et al., "Endogenous Gene and Protein Expression of Drug-Transporting Proteins in Cell Lines Routinely Used in Drug Discovery Programs," Drug Metabolism And Disposition, vol. 37, no. 12, pp. 2275-2283, 2009.
[31]
L. Berglund et al., "A genecentric human protein atlas for expression profiles based on antibodies," Molecular & Cellular Proteomics, vol. 7, no. 10, pp. 2019-2027, 2008.
[32]
L. Berglund et al., "A whole-genome bioinformatics approach to selection of antigens for systematic antibody generation," Proteomics, vol. 8, no. 14, pp. 2832-2839, 2008.
[33]
W. Lu et al., "Sun1 forms immobile macromolecular assemblies at the nuclear envelope," Biochimica et Biophysica Acta. Molecular Cell Research, vol. 1783, no. 12, pp. 2415-2426, 2008.
[34]
J. Patrakka et al., "Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik," Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 689-697, 2007.
[35]
S. Bengtsson et al., "Large-scale proteomics analysis of human ovarian cancer for biomarkers," Journal of Proteome Research, vol. 6, no. 4, pp. 1440-1450, 2007.
[36]
M. Uhlén et al., "A human protein atlas for normal and cancer tissues based on antibody proteomics," Molecular & Cellular Proteomics, vol. 4, no. 12, pp. 1920-1932, 2005.
[37]
P. Nilsson et al., "Towards a human proteome atlas : High-throughput generation of mono-specific antibodies for tissue profiling," Proteomics, vol. 5, pp. 4327-4337, 2005.
[38]
M. G. Koerkamp et al., "Dissection of transient oxidative stress response in Saccharomyces cerevisiae by using DNA microarrays," Molecular Biology of the Cell, vol. 13, no. 8, pp. 2783-2794, 2002.
[39]
C. Szigyarto et al., "L and D presequence peptides derived from the precursor of F1beta subunit of the ATP synthase inhibit mitochondrial protein import by interaction with import machinery.," Plant Molecular Biology, vol. 47, no. 6, 2001.
[40]
A. Stahl et al., "Rapid degradation of the presequence of the F-1 beta precursor of the ATP synthase inside mitochondria," Biochemical Journal, vol. 349, pp. 703-707, 2000.
[41]
C. Szigyarto et al., "A matrix-located processing peptidase of plant mitochondria.," Plant Molecular Biology, vol. 36, no. 1, 1998.
[42]
C. Knorpp, C. Szigyarto and E. Glaser, "Evidence for a novel ATP-dependent membrane-associated protease in spinach leaf mitochondria," Biochemical Journal, vol. 310, pp. 527-531, 1995.
[43]
C. Knorpp, C. Szigyarto and E. Glaser, "Evidence for a novel ATP-dependent membrane-associated protease in spinach leaf mitochondria.," Biochemical Journal, vol. 310 ( Pt 2), 1995.
Conference papers
[44]
F. Huang et al., "Import and processing of nuclear-encoded mitochondrial proteins during development of pea plants : Plant Mitochondria from Gene to Function," in Plant Mitochondria from Gene to Function, 1998.
[45]
C. Szigyarto, V. Salvagnac and E. Glaser, "Proteolysis of Newly imported precursor proteins," in Plant Mitochondria: From gene to function., 1998, pp. 287-290.
[46]
C. Szigyarto and E. Glaser, "Membrane-associated ATP-dependent degradation of mitochondrial precursor proteins : Proteolysis in Cell Functions. V K Hopsu-Havu, M Jarvinen, Heidrun Kirschke," in Proteolysis in Cell Functions., 1997, pp. 298-306.
Non-peer reviewed
Articles
[47]
P. Spitali et al., "Longitudinal proteomic analysis of sera allows to non-invasively monitor disease progression in Duchenne muscular dystrophy," Neuromuscular Disorders, vol. 27, pp. S168-S168, 2017.
[48]
A. Lourbakos et al., "MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen," Human Gene Therapy, vol. 25, no. 11, pp. A27-A28, 2014.
[49]
N. Wein et al., "Successful Use of Out-of-Frame Exon 2 Skipping Induces IRES-Driven Expression of the N-Truncated Dystrophin Isoform : Promising Approach for Treating Other 5 ' Dystrophin Mutations," Molecular Therapy, vol. 22, pp. S294-S295, 2014.
[50]
M. Uhlén et al., "A human protein atlas for normal and disease tissue," Molecular & Cellular Proteomics, vol. 4, no. 8, pp. S15-S15, 2005.
[51]
C. Al-Khalili Szigyarto et al., "High throughput approach for bioinformatic design and cloning of protein epitope sequence tags suitable for antibody generation," Molecular & Cellular Proteomics, vol. 4, no. 8, pp. S60-S60, 2005.
[52]
J. Rockberg, C. A. Szigyarto and M. Uhlén, "Antigen selection for design of protein epitope signature tags," Molecular & Cellular Proteomics, vol. 3, no. 10, pp. S5-S5, 2004.
[53]
C. A. Szigyarto et al., "Statistics of protein epitope signature tag design within the Swedish human proteom resource," Molecular & Cellular Proteomics, vol. 3, no. 10, pp. S91-S91, 2004.
[54]
F. Sterky et al., "Strategies and software for design of protein Epitopes within HPR," Molecular & Cellular Proteomics, vol. 3, no. 10, pp. S4-S4, 2004.
Conference papers
[55]
C. Al-Khalili Szigyarto et al., "Vägen från student till ingenjör : exempel från två kandidatexamenskurser och ett förslag om en programsammanhållande byggnadsställning," in 3:e Utvecklingskonferensen för Sveriges ingenjörsutbildningar. Norrköping, Sweden. 30 november - 1 december 2011, 2011.
Other
[56]
S. Kennedy et al., "Adaptive rewiring of protein-protein interactions and signal flow in the EGFR signaling network by mutant RAS," (Manuscript).
[57]
M. Lindskog et al., "Design of protein epitope signature tags for antibody-based proteomics," (Manuscript).
[58]
C. Johansson et al., "Identification of Gene-Therapy Responsive Blood Biomarkers for Duchenne Muscular Dystrophy," (Manuscript).
[59]
C. Johansson et al., "Monitoring Biomarker Study in Becker Muscular Dystrophy using Data Independent Acquisition LC-MS/MS," (Manuscript).
[60]
E. Fasterius, M. Uhlén and C. Al-Khalili Szigyarto, "Single cell RNA-seq variant analysis for exploration of inter- and intra-tumour genetic heterogeneity," (Manuscript).
[61]
Latest sync with DiVA:
2024-11-21 00:13:02